24.9 C
New York
Tuesday, June 6, 2023

Searching For Real Value In Market Debris At Incyte Corporation (NASDAQ: INCY)

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Incyte Corporation (INCY) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.10, or 0.13%, to $75.44. The Incyte Corporation has recorded 43,641 volume in the after hours trading session. Yahoo Finance discussed the stock recently as it posted Incyte Announces Results from SCRATCH-AD Trial Demonstrating Substantial and Rapid Itch Reduction in Patients with Mild-Moderate Atopic Dermatitis Treated with Opzelura® (ruxolitinib) Cream.

Unlock the Hottest Top 10 Penny Stocks Today! Discover Now

Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.

Gain Access to Top 10 Penny Stocks Now!.


Stocks Info

As a NASDAQ listed company, INCY falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $75.34 and fluctuated between $75.74 as its day high and $74.47 as its day low. The current market capitalization of Incyte Corporation is $16.63B. A total of 1.91 million shares were traded on the day, compared to an average of 1.61M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, INCY has seen 3 BUY and 2 SELL insider trades, representing the acquisition of 43,693 and the disposition of 1,179 shares. Over the last 12 months, there were 58 BUYs and 39 SELLs from insiders. Insiders purchased 388,682 shares during that period but sold 182,476.

In the most recent transaction, Pasquale Maria E sold 802 shares of INCY for 84.06 per share on Jan 31. After the transaction, the EVP & General Counsel now owns 68,524 company shares. In a previous transaction on Jan 30, Pasquale Maria E sold 60,024 shares at 84.74 per share. INCY shares that EVP & General Counsel owns now total 68,524.

Among the insiders who sold shares, Iyengar Vijay K disposed of 7,000 shares on Jan 26 at a per-share price of $85.00. This resulted in the EVP, GMAPPS holding 42,835 shares of INCY after the transaction. In another insider transaction, Dhanak Dashyant sold 2,419 shares at $85.00 per share on Jan 26. Company shares held by the EVP & Chief Scientific Officer now total 53,263.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for INCY in the last 3 months, the mean price target is $88.76 with high estimates of $119.00 and low estimates of $61.00. In terms of 52-week highs and lows, INCY has a high of $86.29 and a low of $65.07.

As of this writing, INCY has an earnings estimate of $0.75 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $1 per share and a lower estimate of $0.46. The company reported an EPS of $0.6 in the last quarter, which was -16.70% lower than expectations of $0.72.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. INCY’s latest balance sheet shows that the firm has $2.35B in Cash & Short Term Investments as of fiscal 2021. There were $34.27M in debt and $885.08M in liabilities at the time. Its Book Value Per Share was $19.63, while its Total Shareholder’s Equity was $3.77B.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 22 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INCY is Sell with a score of 3.88. A total of 9 analysts rated the stock as Buy while 1 rated it as Overweight while 12 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.

Related Articles


Please enter your comment!
Please enter your name here

Latest Articles